× Medicines Discovery Catapult

Our leadership team are determined to reshape the UK’s medicines discovery industry. They specialise in driving scientific innovation, new technologies and encouraging collaboration. They understand the challenges facing medicine discovery and the needs of big pharma, academia, leading technology providers, SMEs, charities and start-ups.

Professor Chris Molloy

Chief Executive Officer

Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. He began in preclinical science and research management at Glaxo, [...]

Read more

Dr Nicola Heron

Chief Business Officer

Nicola has over 22 years’ experience of life science research holding senior positions in both public and private sectors. Her expertise covers research through to commercialisation in pharmaceuticals, medical [...]

Read more

Dr Marcus Harrison

Chief Operating Officer

Marcus joined the Medicines Discovery Catapult as Chief Operating Officer in April 2017 and assumes overall responsibility for the operational functions, including Finance, HR, Facilities, Procurement, IT and Legal [...]

Read more

Professor Peter Simpson

Chief Scientific Officer

Peter has most recently been the Director of N8 Research Partnership, the not-for-profit body that establishes multi-university research collaborations across the North of England. Peter led strategic engagement on [...]

Read more

Professor John Overington

Chief Informatics Officer

In 2017 John joined the Medicines Discovery Catapult as CIO, where he leads the development and application of informatics approaches to promote and support innovative, fast-to-patient drug discovery in [...]

Read more